Kehoe Law Firm, P.C. News Releases

CAPR INVESTOR ALERT: Capricor Therapeutics Securities Class Action Filed; September 28, 2026 Lead Plaintiff Deadline - Kehoe Law Firm

Tue, 11 Aug 2026 12:18:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - August 11, 2026) - Kehoe Law Firm, P.C. announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, both dates inclusive (the "Class Period").Lead Plaintiff Deadline: September 28, 2026. Investors who acquired Capricor securities during the Class Period and...

Ensign Group (ENSG) Investor Alert: Investigation into Potential Fiduciary Duty Breaches - Kehoe Law Firm, P.C.

Mon, 10 Aug 2026 11:26:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - August 10, 2026) - Kehoe Law Firm, P.C. is investigating whether certain officers and directors of The Ensign Group, Inc. ("Ensign," "Ensign Group," or the "Company") (NASDAQ: ENSG) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether Ensign Group and its shareholders may have been harmed as a result.Current Ensign Group shareholders may have rights in...

First BanCorp (FBP) Shareholder Alert: Investigation of Potential Fiduciary Duty Breaches - Kehoe Law Firm, P.C.

Mon, 10 Aug 2026 09:13:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - August 10, 2026) - Kehoe Law Firm, P.C. is investigating whether certain officers and directors of First BanCorp. ("First BanCorp" or the "Company") (NYSE: FBP) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately, and whether the Company and its shareholders may have been harmed as a result.Current First BanCorp shareholders may have rights in connection with the investigation. Additional...

Ensign Group (ENSG) Shareholder Alert: Investigation into Potential Fiduciary Duty Breaches - Kehoe Law Firm, P.C.

Thu, 06 Aug 2026 16:10:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - August 6, 2026) - Kehoe Law Firm, P.C. is investigating whether certain officers and directors of The Ensign Group, Inc. ("Ensign," "Ensign Group," or the "Company") (NASDAQ: ENSG) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether Ensign Group and its shareholders may have been harmed as a result.If you currently own Ensign Group common stock, you may...

ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches

Wed, 05 Aug 2026 12:59:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - August 5, 2026) - Kehoe Law Firm, P.C. is investigating whether certain officers and directors of ADMA Biologics, Inc. ("ADMA," "ADMA Biologics," or the "Company") (NASDAQ: ADMA) may have breached their fiduciary duties or otherwise failed to oversee and manage the Company appropriately. The investigation also concerns whether ADMA Biologics and its shareholders may have been harmed as a result.If you currently own ADMA Biologics common stock, you...

DSGR Shareholder Alert: Kehoe Law Firm, P.C. Investigates Proposed Sale of Distribution Solutions Group

Tue, 21 Jul 2026 14:28:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - July 21, 2026) - Kehoe Law Firm, P.C. is investigating whether the proposed acquisition of Distribution Solutions Group, Inc. ("Distribution Solutions" or the "Company") (NASDAQ: DSGR) by affiliates of LKCM Headwater Investments, LLC ("LKCM Headwater") is fair to the Company's shareholders.On July 16, 2026, Distribution Solutions announced that it had entered into a definitive merger agreement under which newly formed entities controlled by LKCM...

Immix Biopharma Stock Drops Significantly On News of Chief Medical Officer Arrest - IMMX Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims

Mon, 20 Jul 2026 12:13:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - July 20, 2026) - Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Immix Biopharma, Inc. ("Immix Biopharma") (NASDAQ: IMMX). On July 20, 2026, Investing.com reported that "Immix Biopharma Inc . . . shares fell 13% . . . after STAT News reported that one of Rhode Island's most-wanted fugitives appears to have been working as an executive at the company." Additionally, "[a]ccording to the report, Ronald...

Pentair plc Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims - (PNR)

Thu, 16 Jul 2026 09:35:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - July 16, 2026) - Kehoe Law Firm, P.C. is investigating whether Pentair plc ("Pentair" or the "Company") (NYSE: PNR) and certain of its officers or directors violated federal securities laws.On July 14, 2026, Pentair announced preliminary financial results for the second quarter of 2026, substantially reduced its full-year financial guidance, and announced the departure of its Chief Financial Officer.Pentair disclosed that it expected second-quarter...

HUB GROUP - Kehoe Law Firm, P.C. Investigating Potential Securities Fraud Claims on Behalf of Hub Group Investors (HUBG)

Tue, 12 May 2026 10:49:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - May 12, 2026) - Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Hub Group, Inc. ("Hub Group") (NASDAQ: HUBG). On March 12, 2026, Hub Group reported that ". . . the previously issued audited consolidated financial statements of the Company as of and for each of the years ended December 31, 2024 . . . and 2023 . . . included in the Company's Annual Reports on Form 10-K filed on February 25, 2025 and...

ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors

Thu, 07 May 2026 09:16:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - May 7, 2026) - Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of ADMA Biologics, Inc. ("ADMA Biologics" or the "Company") (NASDAQ: ADMA). On May 6, 2026, ADMA Biologics reported that "[b]eginning in the second half of 2025 and continuing into the first quarter of 2026, new FDA-approved IVIG products, and other pharmaceutical products which compete with certain IVIG product uses, entered the market with...